Jackie Hunter, CEO BenevolentBio and Jerome Pesenti, CEO BenevolentTech will be joining Web Summit this year.
Join Jerome Pesenti, CEO BenevolentTech at Founder Forum for a panel on Artificial Intelligence
Join Jackie Hunter, CEO BenevolentBio for the relaunch of Bitesize PhD event series. On this occasion, Jackie will discuss her career and her experience and will answer questions.
Big Data is the process of analysing high volume, high velocity data by advanced computational methods that produce actionable knowledge...
Join Gareth Jones, VP Intellectual Property BenevolentAI at the World IP Summit
Join Ken Mulvany and James Chandler at the CEC Capital Summit
The AI in Bioscience Symposium is an annual one day conference that aims to foster collaboration between experts in AI, technology, academia and the life sciences industry
Amir Saffari, Director of Applied AI will be discussing Machine Learning for Drug Discovery - Join the event
BenevolentAI will be sponsoring MLSB Workshop on Machine Learning in Systems Biology. Our team will be present and we encourage to get in touch. Job opportunities are opened.
Translating UK scientific excellence in global therapeutics strategies
Join the second meet-up of the Special Interest Group on Artificial Intelligence in Biomedicine
Join Jérôme Pesenti on a panel about the impact of artificial intelligence on healthcare at Cognition X event
Meet Jérôme Pesenti, CEO BenevolentTech at Viva Technology in Paris
Celebrate the 10th year of Women in Biotech. Women from across the sector are invited to enjoy an evening of networking, canapes and a thought provoking talk from guest speakers Professor Jackie Hunter and Maxine Mackintosh.
Join Mark Davies for a breakfast on Tuesday 6th June at the Hospital Club and hear from a panel of AI industry experts with first-hand experience building, funding and exiting successful AI companies.
The future of science innovation: building collaborations between academia start-ups and industry
Join a select group of 250 practitioners, researchers, entrepreneurs and investors to explore current and future industry applications of groundbreaking new technologies in healthcare.
Making science personal. Bringing together big pharma, big data and healthcare providers.
Join Jérôme Pesenti, CEO BenevolentTech for a discussion on the impact the digital age is having on our society.
Solving the world’s most pressing challenges through open innovation and partnership.
Only 1 in 5,000 medicines in development make it to market, with a drug typically taking 12 years to develop from initial discovery to market. Estimates vary but the Association of the British Pharmaceutical Industry puts drug development at £1.15bn per drug.
Celebrate the establishment of the first international ChIPs Chapter on Thursday, 27 April 2017 from 5:30PM to 9:00PM at the Supreme Court building, London, United Kingdom. The festivities will include a panel discussion bringing together women leaders from the UK and US, followed by a reception.
Meet Ken Mulvany at Rutberg Summit presenting BenevolentAI's work on Artificial Intelligence applied to drug discovery